Aware Recovery Care Announces Growth Investment from Health Enterprise Partners

Aware Recovery Care, a pioneer in the in-home addiction treatment space, today announced that it has raised a significant growth investment to support rapid expansion and increased access to high-quality, whole-person healthcare. Aware’s In-Home Addiction Treatment (IHAT™) program is backed by a decade of experience delivering individualized, evidence-based treatment, as well as research showing that […]

Aware Recovery Care Announces Growth Investment from Health Enterprise Partners Read More »

CVP Welcomes Tidewater Eye Centers to Its Growing National Ophthalmology Platform

CVP, one of the country’s fastest-growing ophthalmology networks offering world-class eye care, has added Tidewater Eye Centers as a partner practice in its Mid-Atlantic region. This expansion brings together more than 20 physicians, 10 optometrists, two physician assistants, and two surgery centers in the Hampton Roads region of Virginia. Tidewater Eye Centers, with its roots

CVP Welcomes Tidewater Eye Centers to Its Growing National Ophthalmology Platform Read More »

Sharecare Acquires doc.ai

Sharecare, the digital health company that helps people manage all their health in one place, announced Thursday it has entered into a definitive agreement to acquire doc.ai, an enterprise artificial intelligence (AI) platform accelerating digital transformation in healthcare. Through the doc.ai acquisition, Sharecare adds to its team more than 70 engineers with 11 PhDs who

Sharecare Acquires doc.ai Read More »

Branford Castle Reports New Acquisition

Branford Castle, a New York-based private equity company, today announced that its portfolio company, Pulse Veterinary Technologies LLC (PulseVet), has acquired NeoPulse GmbH from Switalis, a leading Switzerland-based shock wave therapy device manufacturer. PulseVet is the leading United States manufacturer and supplier of veterinary shock wave therapy systems. Their ProPulse and previous generation VersaTron systems

Branford Castle Reports New Acquisition Read More »

Catabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc.

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today announced that it has acquired Quellis Biosciences Inc. (“Quellis”), a privately-held emerging biopharmaceutical company focused on discovering best-in-class new molecules to treat serious rare diseases. Concurrent with the acquisition of Quellis, Catabasis entered into a definitive agreement for the sale of Series X convertible preferred stock (the

Catabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc. Read More »

MicroGEM Acquires Jump Start

MicroGEM, a Virginia-based molecular diagnostics company, announced Thursday its acquisition of Jump Start Manufacturing LLC (Jump Start), a New Hampshire-based engineering company with proven success in the biotech and pharmaceutical industry. The acquisition allows MicroGEM to rapidly scale production of its innovative Spitfire6830 SARS-CoV-2 testing system, a high-performance, PCR-based point-of-need saliva test. Read the full

MicroGEM Acquires Jump Start Read More »

Why Florida Is Becoming a Major Battleground for Orthopedics

Florida’s population boom, tax-friendly nature and aging population all contribute to it becoming a key battleground for orthopedic practices. The state’s population soared by more than 240,000 last year, second only to Texas, which gained almost 374,000 people, according to data published by the U.S. Census Bureau in December. Coinciding with this population explosion, two

Why Florida Is Becoming a Major Battleground for Orthopedics Read More »

eHealth Announces Strategic Investment from H.I.G. Capital

eHealth, Inc. (NASDAQ: EHTH) (“eHealth” or the “Company”) today announced that an affiliate of H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm, has entered into a binding agreement to make a $225 million investment in the Company by purchasing convertible preferred stock. eHealth, Inc. (NASDAQ: EHTH) operates a leading health insurance marketplace at eHealth.com

eHealth Announces Strategic Investment from H.I.G. Capital Read More »

Why United Digestive Is Taking a Slow and Steady Approach to Growth

Despite growing at a slower pace than other private equity-backed gastroenterology platforms, Atlanta-based United Digestive is focused on growing its infrastructure to capitalize on future investment. Mark Gilreath, CEO of United Digestive, and Neal C. Patel, MD, chief strategy officer of United Digestive, discussed the platform and its future prospects with Becker’s ASC Review. Read

Why United Digestive Is Taking a Slow and Steady Approach to Growth Read More »

Scroll to Top